Duration of intra-aortic balloon pump use and related complications

Boudoulas, Konstantinos Dean; Bowen, T.; Pederzolli, Andrew; Pfahl, Kyle; Pompili, Vincent J.; Mazzaferri, Ernest L.

doi:10.3109/17482941.2014.889311

Cited by 17 publications

(17 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The incidence of IABP-related vascular complications varied widely, from 0.94% to 31.1% (mean 15.1 ± 12.5). 12 – 18 Only one study distinguished between early and late complications, with early complications being observed in 56 patients (11%). 15 In addition, only a small number of studies (n=5, 20%) divided vascular complications into major and minor.…”

Section: Resultsmentioning

confidence: 99%

Vascular complications following intra-aortic balloon pump implantation: an updated review

et al. 2017

View full text Add to dashboard Cite

Background:The use of the intra-aortic balloon pump (IABP) as a support device remains controversial due to the fact that a number of studies have shown no benefit in end mortality whilst using this device. One of the reasons for this could be the increase in vascular complications when using the pump. Therefore, the aim of the present review was to assess the current literature available with regards to IABP vascular complications during the clinical situation.Methods:A literature search was performed, searching for IABP complications in adult human studies between 1990 and 2016.Results:A total of 20 reports were identified as fitting the criteria of this study. The majority of vascular complications were limb ischemia, bleeding or mesenteric ischemia. The overall incidence of vascular complications ranged from 0.94% to 31.1%. Diabetes, peripheral vascular disease and hypertension, as well as smoking were all identified as risk factors for complications following IABP. Furthermore, studies supported the use of sheathless balloon insertion to reduce the risk of complications.Conclusion:Major vascular complications, including limb and mesenteric ischemia as well as bleeding and hemorrhage, have been associated with IABP. However, the incidence of these complications was generally low. Further studies are still required to truly understand the risk/benefit associated with the use of IABP.

show abstract

Section: Resultsmentioning

confidence: 99%

Vascular complications following intra-aortic balloon pump implantation: an updated review

et al. 2017

View full text Add to dashboard Cite

show abstract

“…Hayıroğlu et al reported on their experience using a femoral IABP inserted percutaneously; 20% of their patients suffered from bleeding and 3% suffered from vascular injury; they did not encounter infections though this is another disadvantage of using the femoral artery as an IABP insertion site . Obviously, our patient population that is in need for long‐term IABP support is at greater risk for these complications …”

Section: Discussionmentioning

confidence: 90%

“…11 Obviously, our patient population that is in need for long-term IABP support is at greater risk for these complications. 12 While some groups have endorsed percutaneous access of the axillary artery for IABP placement, given the proximity of the brachial plexus and the extremely debilitating nature of brachial plexus injury, we prefer an "open" approach to axillary IABP placement. In our practice, axillary IABP opens a novel path of treatment for certain HF patients providing for:…”

Section: Discussionmentioning

confidence: 99%

Controlling axillary intra‐aortic balloon pump inflation is a viable option for turning an acute heart failure patient into a chronic one

et al. 2019

View full text Add to dashboard Cite

Intra‐aortic balloon pump (IABP) is often used to support patients in decompensated heart failure. Placement of the IABP via the axillary artery facilitates long‐term support with the device and may allow for the conversion of an acute heart failure (HF) patient into a chronic HF patient using a modified weaning protocol; allowing for medical symptom management and removal of mechanical support. We will discuss strategies for supporting these complicated patients.

show abstract

“…12,14, 15 In contrast, longer IABP support increases vascular or hemorrhagic complications. 35 Although the absolute duration of IABP support varies strongly with institution, early insertion of IABP before end-organ dysfunction exceeds the reversible threshold, is essential. We maintained duration of IABP support at <1 week.…”

Section: Optimal Timing Of Iabpmentioning

confidence: 99%

Prophylactic Intra-Aortic Balloon Pump Before Ventricular Assist Device Implantation Reduces Perioperative Medical Expenses and Improves Postoperative Clinical Course in INTERMACS Profile 2 Patients

Imamura

Kinugawa

Nitta

et al. 2015

Circ J

View full text Add to dashboard Cite

Duration of intra-aortic balloon pump use and related complications

Abstract: When an IABP was used for more than two days complications significantly increased. The clinical implications of the study will be strengthened if the findings are confirmed in a prospective study with a larger number of patients.

Cited by 17 publications

References 25 publications

Vascular complications following intra-aortic balloon pump implantation: an updated review

Vascular complications following intra-aortic balloon pump implantation: an updated review

Controlling axillary intra‐aortic balloon pump inflation is a viable option for turning an acute heart failure patient into a chronic one

Prophylactic Intra-Aortic Balloon Pump Before Ventricular Assist Device Implantation Reduces Perioperative Medical Expenses and Improves Postoperative Clinical Course in INTERMACS Profile 2 Patients

Contact Info

Product

Resources

About